Brain Circuit Associated With MS-related Depression Identified
Researchers have identified specific areas of brain damage associated with depression in multiple sclerosis (MS), but not with other…
Articles by Marisa Wexler, MS
FSD Asking to Open Trial of Lucid-MS, Myelin-protecting Therapy
FSD Pharma has submitted an application to Health Canada asking to start a Phase 1 clinical trial of…
Pheno, UCB Team Up to Bring New Remyelination Therapies to Trial
Pheno Therapeutics has entered into an agreement with UCB to develop new therapies aimed at remyelination to treat…
Exosome-based Therapy Eases Disease in MS Mouse Model
A new therapy that delivers an anti-inflammatory compound to nervous system immune cells via cellular “shipping containers” called exosomes showed…
Neural Stem Cell Therapy for MS Tolerated Well in Small Phase 1 Study
A treatment containing neural stem cells derived from a human fetus was shown to be well tolerated in a small…
COVID-19 Could Trigger MS Via ‘Molecular Mimicry,’ Study Shows
A protein in the virus that causes COVID-19 is structurally similar to several proteins targeted by the immune system in…
Differences in Bacteria, Viruses in MS Patients’ Guts Seen in Study
The amounts of more than 60 species of bacteria are altered in the gut in people with multiple sclerosis…
Use of ‘Tattoo Gun’ Device Found to Greatly Reduce MS Severity in Mice
Multiple tiny injections of myelin-related small proteins alongside suppressors of the activity of dendritic cells, done using a device akin…
How ‘Medical Gaslighting’ Affects Women With Chronic Illness: Study
Women with chronic health conditions like multiple sclerosis (MS) often experience disbelief and disenfranchisement from healthcare providers when they…
Trial Testing Safety, Efficacy of Ginger Supplements in RRMS
Researchers in Iran are conducting a clinical trial to test the effects of taking ginger supplements for people with…
Top 10 MS Stories of 2022
Multiple Sclerosis News Today brought consistent coverage of the latest scientific research, developments in treatment, and clinical trials for…
Cutting Brain-gut Vagus Nerve Lessens Loss of Myelin in MS Mice
Severing the lower part of the vagus nerve — one of the main neurological pathways that connects the brain to…
Foralumab Nasal Spray for MS Well-tolerated in Mice for 3 Months
Foralumab, a nasal spray therapy that Tiziana Life Sciences is developing for multiple sclerosis (MS) and other disorders,…
MS TreatSim Program Allows Simulation of RRMS Clinical Trials
Researchers have created a computer program that can simulate clinical trial responses for relapsing-remitting multiple sclerosis (RRMS), which may…
Testing for 4 Gene Variations May Predict Risk of PML Brain Infection
Genetic variations in certain genes may increase the risk of developing progressive multifocal leukoencephalopathy (PML), a serious brain infection…
1st Abata Candidate Will Be T-cell Therapy ABA-101 for Progressive MS
Abata Therapeutics has chosen its first treatment candidate for development: the T-cell therapy ABA-101 for certain forms of progressive…
Bright Light Therapy Shows Promise for Easing MS Fatigue in Small Trial
Daily exposure to 30 minutes of bright light for two weeks led to clinically significant reductions in fatigue scores…
New Machine Learning Algorithm May Better Predict Severity in MS
A machine learning algorithm that incorporates genetic data alongside clinical and demographic information may be able to more accurately predict…
Novel CAR T-cell Therapy Shows Promise in MS Mouse Study
Researchers have developed a technique that uses CAR T-cells, a form of cell therapy, to specifically eliminate the self-reactive immune…
Gut Microbiome Composition May Help Predict Treatment Side Effects
Differences in the composition of the gut microbiome are associated with an altered risk of low immune cell counts as…
After Stabilizing Treatment, Disease Activity Predicts Outcome in Study
Assessing disease activity from the first to second year after a diagnosis of multiple sclerosis (MS), once treatment has…
Electrical Stimulation Helps With Bladder Control in MS, Study Finds
Posterior tibial nerve stimulation (PTNS) — a procedure that delivers electrical stimulation to the bladder through nerves in the leg…
Removing Transporter Protein Spns2 Protects Against MS in Mice
Blocking the activity of Spns2, a transporter of the sphingosine 1-phosphate (S1P) protein, reduced the severity of multiple sclerosis…
Switching to Ocrevus Over Other MS Therapies Means Fewer Relapses
People with relapsing-remitting multiple sclerosis (RRMS) who switch to Ocrevus (ocrelizumab) after discontinuing Gilenya (fingolimod) have fewer relapses…
Add-on Supplement May Bolster Interferon Therapies for RRMS
A dietary supplement called Neuroaspis plp10 significantly lowered relapse rates and slowed disability progression among people with relapsing-remitting multiple sclerosis…
Panel Calls for New Way to Classify MS Based on Underlying Biology
An international panel is calling for new methods to classify multiple sclerosis (MS) that reflect the disease’s underlying biology,…
MS Patients Help Steer Guidelines for Talks About Brain Volume Loss
A team of doctors, researchers, and patients has come up with a set of recommendations to help medical professionals in…
2 Years of Vidofludimus Calcium Thwarts Disability Progression: Data
Most adults with relapsing-remitting multiple sclerosis (RRMS) who received Immunic Therapeutics‘ investigational therapy vidofludimus calcium have had…
Effect of Diabetes Medicines on MS Risk Varies by Age, Sex in US Study
Among people with type 2 diabetes, the use of anti-hyperglycemic medications is associated with a reduced risk of…
New Test Reveals Slower Signals Between Brain Regions in Patients
Using a new approach to track signals traveling between different brain regions, researchers found that these signals are slower in…